Urihold 50mg Tablet ER

Introduction

Urihold is a prescription medication that contains the active ingredient Mirabegron. It is available under the brand name Urihold. Mirabegron is a medication that is primarily used to treat overactive bladder (OAB) symptoms, such as frequent urination, urgency, and urinary incontinence.

Uses

Urihold is prescribed to manage the symptoms of overactive bladder (OAB) in adults. OAB is a condition characterized by a sudden and uncontrollable urge to urinate, frequent urination, and urinary incontinence.

Dosage and Administration

• The recommended dosage of Urihold is typically one tablet taken orally once daily.
• follow the instructions provided by your healthcare professional regarding the dosage and duration of treatment.
• The tablet should be swallowed whole and should not be crushed, chewed, or broken.

Mechanism of Action

Urihold contains Mirabegron, which belongs to a class of medications known as beta-3 adrenergic agonists. It works by relaxing the smooth muscles of the bladder, thereby increasing the bladder’s capacity to hold urine and reducing the frequency of urination.

Side Effects

Common side effects of Urihold may include:

• Increased blood pressure
• Headache
• Urinary tract infection
• Nasopharyngitis (common cold symptoms)
• Diarrhea

Serious side effects are rare, but if you experience any of the following, seek immediate medical attention:

• Allergic reactions (such as rash, itching, swelling, severe dizziness, or difficulty breathing)
• Severe or persistent headache
• Chest pain or palpitations
• Blood in urine

If you experience any side effects while taking Urihold, contact your healthcare professional.

Drug Interactions

Urihold may interact with certain medications, including:

• Beta-blockers (e.g., metoprolol)
• Calcium channel blockers (e.g., verapamil)
• Digoxin
• Diuretics (e.g., furosemide)
• Potassium-sparing diuretics (e.g., spironolactone)

inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products, to avoid potential drug interactions.

Precautions

Before taking Urihold, consider the following precautions:

• Inform your healthcare professional if you have any allergies or medical conditions, especially if you have liver or kidney problems.
• Urihold may increase blood pressure, so monitor your blood pressure regularly.
• If you experience difficulty emptying your bladder completely or have a history of urinary retention, consult your healthcare professional before taking this medication.
• Avoid consuming alcohol while taking Urihold, as it may increase the risk of side effects.

Storage

Urihold should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

Here are some additional tips for patients using Urihold:

• Take the medication at the same time each day to help you remember to take it.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• It may take a few weeks for Urihold to start working effectively. Continue taking the medication as prescribed, even if you do not notice immediate improvement.
• Maintain good bladder habits, such as drinking adequate fluids, avoiding excessive caffeine intake, and practicing pelvic floor exercises as recommended by your healthcare professional.
• If you have any questions or concerns about Urihold, do not hesitate to consult your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Mirabegron: medicine to treat the symptoms of an overactive bladder (NHS UK) [Accessed 6 Jun. 2024] (online) Available at:
• Betmiga 25 mg prolonged-release tablets (Health Professionals SmPC) Available at:
• Mirabegron (Drugs.com) [Accessed 5 Jun. 2024] (online) Available at:
• myrbetriq (mirabegron) (RX) [Accessed 13 Jun. 2024] (online) Available at:
• Mirabegron (MedlinePlus) [Accessed 30 Jun. 2024] (online) Available at:
• Keam SJ. Mirabegron: Pediatric First Approval. Paediatr Drugs. 2021 Jul;23(4):411-415. doi: 10.1007/s40272-021-00452-4. [Accessed 4 Jun. 2024] Available at: